Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 5235-5239, November 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coufalik, A. H.
Right arrow Articles by Hollander, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coufalik, A. H.
Right arrow Articles by Hollander, V. P.

Use of Chromatofocusing to Distinguish Estradiol Receptor from Ovarian-dependent and -independent Rat Mammary Tumors1

Alena H. Coufalik, Mark Feldman, Micsunica Platica, Lewis Toth, David Dreiling and Vincent P. Hollander2

Departments of Surgery and Neoplastic Diseases [A. H. C., M. F., M. P., V. P. H.] and The Center for Laboratory Animal Sciences [L. T., D. D.], Mount Sinai School of Medicine, New York, New York 10029

Cytosol estradiol receptor from MTW9-D (ovarian dependent) and MTW9-MtT (ovarian independent) rat mammary tumors were fractionated by chromatofocusing, a procedure which separates proteins on an ion-exchange column as a function of isoelectric point. Receptor from MTW9-D usually fractionated as three peaks with mean pH at peak height of 7.5, 6.8, and 6.0. The intermediate peak at pH 6.8 was present in 90% of MTW9-D tumors examined but in only 20% of MTW9-MtT tumors. Treatment of cytosols with 20 mM sodium molybdate or 50 mM leupeptin did not change the chromatofocusing profiles.

The pl 6.8 fraction of receptor bound quantitatively to DNA-cellulose after ammonium sulfate precipitation, while receptor in the other two peaks bound much less. The quantitative binding of a fraction of estradiol receptor characteristic of MTW9-D to DNA is consistent with the greater binding of unfractionated cytosol receptor from MTW9-D to DNA than the binding of receptor from MTW9-MtT. Sucrose gradient analysis of the pl 6.8 receptor showed a sedimentation coefficient slightly less than ovalbumin with a Stokes radius of 26 Å as determined by agarose chromatography. The correlation of receptor binding to DNA with response to ovariectomy might make this form of receptor a potential marker of hormonal responsivity in mammary tumors.

1 This investigation was supported by Grant BC-312 from The American Cancer Society.

2 To whom requests for reprints should be addressed.

Received 1/25/83. Accepted 8/ 3/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.